EMFAT
ITCI
Emerald Mutual Fund Advisers Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-284,657
| Closed | -$23.8M | – | 237 |
|
|
2024
Q4 | $23.8M | Sell |
284,657
-50,016
| -15% | -$4.18M | 1.45% | 15 |
|
|
2024
Q3 | $24.5M | Buy |
334,673
+20,622
| +7% | +$1.51M | 1.27% | 25 |
|
|
2024
Q2 | $21.5M | Buy |
314,051
+1,920
| +0.6% | +$132K | 1.13% | 31 |
|
|
2024
Q1 | $21.6M | Buy |
312,131
+31,542
| +11% | +$2.18M | 1.12% | 30 |
|
|
2023
Q4 | $20.1M | Sell |
280,589
-30,849
| -10% | -$2.21M | 1.06% | 31 |
|
|
2023
Q3 | $16.2M | Buy |
311,438
+34,935
| +13% | +$1.82M | 0.98% | 37 |
|
|
2023
Q2 | $17.5M | Buy |
+276,503
| New | +$17.5M | 0.95% | 44 |
|